Trial intelligence / Profile preview

Emla cream versus diclofenac gel for chemo port pain

IRCT2017080635520N1Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of prilocaine and diclofenac in cancer (2 arms), sponsored by Zahedan University of Medical Sciences. Started Mar 2017; status: completed.

02

Drugs

prilocainediclofenac
03

Conditions

cancer

Beyond the preview

Go deeper on IRCT2017080635520N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017080635520N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call